Angiotensin II (AngII), a circulating vasoactive pep tide, interacts w
ith specific membrane-bound receptors on the target tissues (vessels,
kidneys and adrenal gland). Using new pharmacological tools and molecu
lar cloning, these receptors have been classified in two types, called
AT(1) et AT(2), whereas two subtypes, called AT(1A) et AT(1B), have b
een identified for the rodent AT(1) receptors, but not in humans. All
these receptors present a seven hydrophobic transmembrane domain struc
ture, which is classical for G protein coupled receptors. The interspe
cies molecular homology of these AngII receptors is high (>90 per cent
identity) within the same type of receptor, but is rather low (approx
imate to 35 per cent identity) between the two types of receptors. The
AT(1) receptors are responsible for most of the AngII physiological a
ctions and are coupled to a Gq protein, which activates a phospholipas
e C producing second messengers which activate protein kinases C and m
obilize calcium intracellular stores. More recently, a strong interact
ion of this receptor has been demonstrated with the signalling pathway
s of the tyrosine kinases. The molecular mechanisms and the physiologi
cal importance of these interactions remain to be elucidated. The intr
acellular signalling (Gi coupling and tyrosine phosphatase activation)
and the physiological actions (cellular differentiation, apoptosis) o
f the AT(2) receptors are more controversial.